ArticleCommunications biology2025
Integrative analysis of 115 transcriptomic studies decodes the molecular landscape of neurodevelopmental disorders.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neural peer pressure: intercellular dynamics and emergent phenotypes in the mosaic Rett syndrome brain.Cell communication and signaling : CCS · 2026Review
- Multi-omics characterization of developing forebrain organoids unravels the dynamic molecular events of Rett syndrome pathogenesis.Journal of neurodevelopmental disorders · 2026Article
- MeCP2 at the crossroads of hypoxia, oxidative stress, and gene regulation in Rett syndrome.Epigenomics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the low disease prevalence, transcriptomic studies of neurodevelopmental disorders (NDDs) often face limited statistical power, constraining the depth of insights they can provide. To tackle this limitation, we integrated 151 human RNA sequencing datasets from 115 independent studies, and characterized the common and distinct molecular pathways of NDDs and their neurological phenotypes. In addition to revealing an aberrant expression profile of imprinted genes, our analysis identified transcriptomic changes in inflammatory, translational, mitochondrial, and synaptic processes across the different NDDs. We further highlight disorder-associated alterations, including upregulation of ITGB4 across Rett syndrome datasets. Moreover, gene expression changes in LHX1/5-mediated cerebellar Purkinje cell layer formation were found to be specific to seizure-associated NDDs. We combined the datasets into a publicly accessible NDD transcriptomic atlas: https://SyNUM.shinyapps.io/NDD-transcriptomic-atlas/ . Together, our findings provide fundamental insights into the molecular pathophysiology of NDDs and highlight genes and pathways with aberrant transcriptomic profiles. This knowledge can guide future therapeutic development and precision medicine approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.